College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Biochem Pharmacol. 2018 Aug;154:278-292. doi: 10.1016/j.bcp.2018.05.014. Epub 2018 May 24.
Acetaminophen (APAP) overdose treatment causes severe liver injury. Adiponectin, a hormone predominantly produced by adipose tissue, exhibits protective effects against APAP-induced hepatotoxicity. However, the underlying mechanisms are not clearly understood. In the present study, we examined the protective effect of globular adiponectin (gAcrp) on APAP-induced hepatocyte death and its underlying mechanisms. We found that APAP (2 mM)-induced hepatocyte death was prevented by inhibition of the inflammasome. In addition, treatment with gAcrp (0.5 and 1 μg/ml) inhibited APAP-induced activation of the inflammasome, judged by suppression of interleukin-1β maturation, caspase-1 activation, and apoptosis-associated speck-like protein (ASC) speck formation, suggesting that protective effects of gAcrp against APAP-induced hepatocyte death is mediated via modulation of the inflammasome. APAP also induced ER stress and treatment with tauroursodeoxycholic acid (TUDCA), an ER chaperone and inhibitor of ER stress, abolished APAP-induced inflammasomes activation, implying that ER stress acts as signaling event leading to the inflammasome activation in hepatocytes stimulated with APAP. Moreover, gAcrp significantly suppressed APAP-induced expression of ER stress marker genes. Finally, the modulatory effects of gAcrp on ER stress and inflammasomes activation were abrogated by treatment with autophagy inhibitors, while an autophagy inducer (rapamycin) suppressed APAP-elicited ER stress, demonstrating that autophagy induction plays a crucial role in the suppression of APAP-induced inflammasome activation and ER stress by gAcrp. Taken together, these results indicate that gAcrp protects hepatocytes against APAP-induced cell death by modulating ER stress and the inflammasome activation, at least in part, via autophagy induction.
对乙酰氨基酚(APAP)过量会导致严重的肝损伤。脂联素是一种主要由脂肪组织产生的激素,对 APAP 诱导的肝毒性具有保护作用。然而,其潜在机制尚不清楚。在本研究中,我们研究了球状脂联素(gAcrp)对 APAP 诱导的肝细胞死亡的保护作用及其潜在机制。我们发现,炎症小体的抑制可预防 APAP(2mM)诱导的肝细胞死亡。此外,用 0.5 和 1μg/ml 的 gAcrp 处理可抑制 APAP 诱导的炎症小体激活,判断依据为白细胞介素-1β成熟、半胱天冬酶-1 激活和凋亡相关斑点样蛋白(ASC)斑点形成的抑制,提示 gAcrp 对 APAP 诱导的肝细胞死亡的保护作用是通过调节炎症小体介导的。APAP 还诱导内质网应激,内质网伴侣和内质网应激抑制剂牛磺熊脱氧胆酸(TUDCA)的处理消除了 APAP 诱导的炎症小体激活,表明内质网应激作为信号事件导致 APAP 刺激的肝细胞中炎症小体的激活。此外,gAcrp 显著抑制了 APAP 诱导的内质网应激标记基因的表达。最后,用自噬抑制剂处理可消除 gAcrp 对内质网应激和炎症小体激活的调节作用,而自噬诱导剂(雷帕霉素)抑制了 APAP 引起的内质网应激,表明自噬诱导在 gAcrp 抑制 APAP 诱导的炎症小体激活和内质网应激中起着关键作用。综上所述,这些结果表明 gAcrp 通过调节内质网应激和炎症小体激活来保护肝细胞免受 APAP 诱导的细胞死亡,至少部分通过自噬诱导。